RxDoctor Payments Data

Linda Flynn, MD

Procedural Dermatology · Tampa, FLNPI 1194854679

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 28.2% of the total.

$3,902in general payments, 2019–2025

Across 137 payments — averaging $28.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merz North America, Inc.$487
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$368
  • Galderma Laboratories, L.p.$359
  • Johnson & Johnson$316
  • Sun Pharmaceutical Industries Inc.$258
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$3,80097%
  • Education$1023%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,902 in reported general payments places this provider in the 70th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$169,619
Medicare patients
569
Services billed
2,785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin136$864
Doxycycline Hyclate25$852
Metronidazole25$801
Ketoconazole56$718
Clobetasol Propionate12$529
CiclopiroxCiclopirox Olamine13$527
Betamethasone Dipropionate17$415
Triamcinolone Acetonide25$229
Mometasone Furoate13$229
Hydrocortisone33$140

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →